REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 MOIRA MCMAHON, Johns Hopkins University, Baltimore
The hepatitis B drug entecavir appears to select for a drug resistant HIV mutation – and this has implications for patients infected with both viruses. Derek Thorne got the details from Moira McMahon from Johns Hopkins University in Baltimore. .
CHLOE THIO, Johns Hopkins University School of Medicine
REFERENCE: Abstract: 136LB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February
Mitchell Shiffman
REFERENCE: N Engl J Med 2007;357:124-34
MITCHELL SHIFFMAN, Virginia Commonwealth University, Richmond
Standard anti-viral therapy for Hepatitis
Post a comment